Relmada Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
CEOSergio Traversa
CEOSergio Traversa
Employees17
Employees17
HeadquartersCoral Gables, Florida
HeadquartersCoral Gables, Florida
Founded2012
Founded2012
Employees17
Employees17
RLMD Key Statistics
Market cap19.92M
Market cap19.92M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume439.23K
Average volume439.23K
High today$0.65
High today$0.65
Low today$0.59
Low today$0.59
Open price$0.6061
Open price$0.6061
Volume194.61K
Volume194.61K
52 Week high$4.47
52 Week high$4.47
52 Week low$0.2404
52 Week low$0.2404
People also own
Based on the portfolios of people who own RLMD. This list is generated using Robinhood data, and it’s not a recommendation.